Literature DB >> 9549250

Nicotine: abused substance and therapeutic agent.

J Le Houezec1.   

Abstract

Tobacco dependence is a complex phenomenon that is not fully understood. Nicotine is the main alkaloid in tobacco and the addictive compound of tobacco. It can improve both mood and cognitive functioning; these positive effects are strong reinforcements for smokers and contribute to their addiction. Opposite results also have been reported, however, and the effects of nicotine remain controversial. Recent epidemiological and empirical studies have indicated that smoking or nicotine or both may have protective effects against certain diseases. These findings have suggested that nicotine may be used as a therapeutic agent. However, because a variety of nicotinic cholinergic receptors are present in the brain, new agonist compounds may prove to be more effective than nicotine for therapeutic purposes. Studies are reviewed and the suggestion made that nicotine may prove useful as a tool to help us understand normal and pathological brain functioning.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9549250      PMCID: PMC1188908     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  111 in total

1.  Acute nicotinic blockade produces cognitive impairment in normal humans.

Authors:  P A Newhouse; A Potter; J Corwin; R Lenox
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Nasal nicotine spray: a rapid nicotine delivery system.

Authors:  G Sutherland; M A Russell; J Stapleton; C Feyerabend; O Ferno
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine.

Authors:  W A Corrigall; K B Franklin; K M Coen; P B Clarke
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

4.  The effects of nicotine plus haloperidol compared to nicotine only and placebo nicotine only in reducing tic severity and frequency in Tourette's disorder.

Authors:  B J McConville; P R Sanberg; M H Fogelson; J King; P Cirino; K W Parker; A B Norman
Journal:  Biol Psychiatry       Date:  1992-04-15       Impact factor: 13.382

5.  Nicotine withdrawal symptoms and psychiatric disorders: findings from an epidemiologic study of young adults.

Authors:  N Breslau; M M Kilbey; P Andreski
Journal:  Am J Psychiatry       Date:  1992-04       Impact factor: 18.112

6.  Rate of increase of plasma drug level influences subjective response in humans.

Authors:  H de Wit; B Bodker; J Ambre
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

7.  Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment.

Authors:  M J Marks; J R Pauly; S D Gross; E S Deneris; I Hermans-Borgmeyer; S F Heinemann; A C Collins
Journal:  J Neurosci       Date:  1992-07       Impact factor: 6.167

8.  Nicotinic systems and cognitive function.

Authors:  E D Levin
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

9.  Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects.

Authors:  D C Goff; D C Henderson; E Amico
Journal:  Am J Psychiatry       Date:  1992-09       Impact factor: 18.112

10.  Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease.

Authors:  G M Jones; B J Sahakian; R Levy; D M Warburton; J A Gray
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more
  6 in total

1.  Effects of nicotine chewing gum on a real-life motor task: a kinematic analysis of handwriting movements in smokers and non-smokers.

Authors:  Oliver Tucha; Klaus W Lange
Journal:  Psychopharmacology (Berl)       Date:  2003-12-11       Impact factor: 4.530

Review 2.  Pharmacological perspectives on the detoxification of plant secondary metabolites: implications for ingestive behavior of herbivores.

Authors:  Stuart McLean; Alan J Duncan
Journal:  J Chem Ecol       Date:  2006-05-23       Impact factor: 2.626

Review 3.  Targeting neuronal dysfunction in schizophrenia with nicotine: Evidence from neurophysiology to neuroimaging.

Authors:  Jason Smucny; Jason R Tregellas
Journal:  J Psychopharmacol       Date:  2017-04-26       Impact factor: 4.153

Review 4.  Nicotinic modulation of intrinsic brain networks in schizophrenia.

Authors:  Jason Smucny; Jason Tregellas
Journal:  Biochem Pharmacol       Date:  2013-06-21       Impact factor: 5.858

Review 5.  Reevaluating the nicotine delivery kinetics hypothesis.

Authors:  Reuven Dar; Hanan Frenk
Journal:  Psychopharmacology (Berl)       Date:  2007-04-03       Impact factor: 4.415

6.  Smoking and mental health.

Authors:  Hamid Ghodse
Journal:  Int Psychiatry       Date:  2007-01-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.